Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

por Komers, Radko, Diva, Ulysses, Inrig, Jula K., Loewen, Andrea, Trachtman, Howard, Rote, William E.
Publicado 2020

IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study

por Barratt, Jonathan, Rovin, Brad, Wong, Muh Geot, Alpers, Charles E., Bieler, Stewart, He, Ping, Inrig, Jula, Komers, Radko, Heerspink, Hiddo J.L., Mercer, Alex, Noronha, Irene L., Radhakrishnan, Jai, Rheault, Michelle N., Rote, William, Trachtman, Howard, Trimarchi, Hernán, Perkovic, Vlado
Publicado 2023